The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2
Open accessAbstract
Inflammation associates with peripheral insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. Inflammation induces the expression of SOCS proteins. We show that SOCS1 or SOCS3 targeted IRS1 and IRS2, two critical signaling molecules for insulin action, for ubiquitin-mediated degradation. SOCS1 or SOCS3 bound both recombinant and endogenous IRS1 and IRS2 and promoted their ubiquitination and subsequent degradation in multiple cell types. Mutations in the conserved SOCS box of SOCS1 abrogated its interaction with the elongin BC ubiquitin-ligase complex without affecting its binding to IRS1 or IRS2. The SOCS1 mutants also failed to promote the ubiquitination and degradation of either IRS1 or IRS2. Adenoviral-mediated expression of SOCS1 in mouse liver dramatically reduced hepatic IRS1 and IRS2 protein levels and caused glucose intolerance; by contrast, expression of the SOCS1 mutants had no effect. Thus, SOCS-mediated degradation of IRS proteins, presumably via the elongin BC ubiquitin-ligase, might be a general mechanism of inflammation-induced insulin resistance, providing a target for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obesity-related insulin resistance could result from a diminution in insulin receptor substrate-1 (IRS-1) in animals, secondary to an increase in suppressor of cytokine signaling 3 (SOCS-3), which binds to IRS-1 and leads to its ubiquitylation and proteolysis in experimental animals [5]”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-378 · Cited by 826
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Zhang, J., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R. T., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 626
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 899
Galić, S., Sachithanandan, N., Kay, T. W. H., & Steinberg, G. R. (2014) · Biochemical Journal · doi:10.1042/bj20140143 · Cited by 100
SOCS proteins in regulation of receptor tyrosine kinase signaling
Kazi, J. U., Kabir, N. N., Flores-Morales, A., & Rönnstrand, L. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1619-y · Cited by 103
Mittal, K., Mani, R. J., & Katare, D. P. (2016) · Scientific Reports · doi:10.1038/srep25589 · Cited by 101
Ghanim, H., Aljada, A., Daoud, N., Deopurkar, R., Chaudhuri, A., & Dandona, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0508-9 · Cited by 96
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover
Orr, S. J., Morgan, N. M., Elliott, J., Burrows, J. F., Scott, C. J., McVicar, D. W., & Johnston, J. A. (2006) · Blood · doi:10.1182/blood-2006-05-023556 · Cited by 96
Inhibition of the Src and Jak Kinases Protects against Lipopolysaccharide-induced Acute Lung Injury
Severgnini, M., Takahashi, S., Tu, P., Perides, G., Homer, R., Jhung, J. W., Bhavsar, D., Cochran, B., & Simon, A. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-981oc · Cited by 93
Schwartz, M. W., & Niswender, K. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0906 · Cited by 93
Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway
Zhang, Y., Zhou, B., Zhang, F., Wu, J., Hu, Y., Liu, Y., & Zhai, Q. (2012) · Diabetes · doi:10.2337/db11-0499 · Cited by 92
Morris, D. L., Cho, K. W., Zhou, Y., & Rui, L. (2009) · Diabetes · doi:10.2337/db08-1388 · Cited by 94
Hyperglycaemia and pulmonary infection
Baker, E. H., Wood, D. M., Brennan, A. L., Clark, N., Baines, D. L., & Philips, B. J. (2006) · Proceedings of The Nutrition Society · doi:10.1079/pns2006499 · Cited by 92
Clementi, A. H., Gaudy, A. M., van Rooijen, N., Pierce, R. H., & Mooney, R. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.007 · Cited by 95
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01143 · Cited by 93
Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)
Yang, Z., Hulver, M., McMillan, R. P., Cai, L., Kershaw, E. E., Yu, L., Xue, B., & Shi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047493 · Cited by 90
Leng, S.-H., Zhang, W., Zheng, Y., Liberman, Z., Rhodes, C. J., Eldar-Finkelman, H., & Sun, X. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0456 · Cited by 91
PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
Vinciguerra, M., & Foti, M. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600711359 · Cited by 91
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7796727 · Cited by 91
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
Nagarajan, A. G., Petersen, M. C., Nasiri, A. R., Butrico, G. M., Fung, A. C. H., Ruan, H., Kursawe, R., Caprio, S., Thibodeau, J., Bourgeois‐Daigneault, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12639 · Cited by 89
SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses
Huang, S., Liu, K., Cheng, A., Wang, M., Cui, M., Huang, J., Zhu, D., Chen, S., Liu, M., Zhao, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.558341 · Cited by 90
Luo, Z., Zhang, Y., Li, F., He, J., Ding, H., Yan, L., & Cheng, H. (2009) · Endocrine · doi:10.1007/s12020-009-9198-7 · Cited by 89
SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?
Mahony, R., Ahmed, S., Diskin, C., & Stevenson, N. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2234-x · Cited by 89
Serrano-Marco, L., Barroso, E., Kochairi, I. E., Palomer, X., Michalik, L., Wahli, W., & Vázquez‐Carrera, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2401-4 · Cited by 87
Regulation of Receptor Tyrosine Kinase Signaling by GRKs and β-Arrestins
Hupfeld, C. J., & Olefsky, J. M. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154626 · Cited by 86
Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016
Saitoh, M., Ishida, J., Doehner, W., von Haehling, S., Anker, M. S., Coats, A. J. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.155 · Cited by 85
Jin, H., Shao, J.-Z., Xiang, L.-X., Wang, H., & Sun, L.-L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.015 · Cited by 85
Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase
Yoneyama, Y., Inamitsu, T., Chida, K., Iemura, S., Natsume, T., Maeda, T., Hakuno, F., & Takahashi, S. (2018) · iScience · doi:10.1016/j.isci.2018.06.006 · Cited by 90
Cullin-RING Ligase 5: Functional characterization and its role in human cancers
Zhao, Y., Xiong, X., & Sun, Y. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.04.003 · Cited by 82
(2008) · PubMed · Cited by 84
Faßhauer, M., Kralisch, S., Klier, M., Lössner, U., Blüher, M., Klein, J. C., & Paschke, R. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810129 · Cited by 83
Zhu, Y., Mordaunt, C. E., Yasui, D. H., Marathe, R., Coulson, R. L., Dunaway, K. W., Jianu, J. M., Walker, C. K., Ozonoff, S. J., Hertz‐Picciotto, I., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz084 · Cited by 89
Oncogenic aberrations of cullin-dependent ubiquitin ligases
Guardavaccaro, D., & Pagano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207413 · Cited by 84
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior
Pierconti, F., Martini, M., Pinto, F., Cenci, T., Capodimonti, S., Calarco, A., Bassi, P. F., & Larocca, L. M. (2010) · The Prostate · doi:10.1002/pros.21245 · Cited by 82
Ishizuka, K., Usui, I., Kanatani, Y., Bukhari, A., He, J., Fujisaka, S., Yamazaki, Y., Suzuki, H., Hiratani, K., Ishiki, M., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1702 · Cited by 82
Deng, K., Pan, M., Liu, J., Yang, M., Gu, Z., Zhang, Y., Liu, G., Liu, D., Zhang, W., & Mai, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-25412-w · Cited by 84
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 86
Tawulie, D., Jin, L., Shang, X. C., Li, Y., Sun, L., Xie, H., Zhao, J., Liao, J., Zhu, Z., Cui, H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154733 · Cited by 82
Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity
Fukushima, T., Yoshihara, H., Furuta, H., Kamei, H., Hakuno, F., Luan, J. Y., Duan, C., Saeki, Y., Tanaka, K., Iemura, S.-I., et al. (2015) · Nature Communications · doi:10.1038/ncomms7780 · Cited by 77
Kurdi, M., & Booz, G. W. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318068dd49 · Cited by 80
Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease
Morris, J. K., Zhang, H., Gupte, A. A., Bomhoff, G. L., Stanford, J. A., & Geiger, P. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.089 · Cited by 79
Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
Sharma, J., & Larkin, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00324 · Cited by 77
Russell, R. C., Sufan, R. I., Zhou, B. R., Heir, P., Bunda, S., Sybingco, S. S., Greer, S. N., Roche, O., Heathcote, S. A., Chow, V. W. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2370 · Cited by 79
Serrano, L., Rodríguez‐Calvo, R., Kochairi, I. E., Palomer, X., Michalik, L., Wahli, W., & Vázquez‐Carrera, M. (2011) · Diabetes · doi:10.2337/db10-0704 · Cited by 80
Qing, Y., Costa‐Pereira, A. P., Watling, D., & Stark, G. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409863200 · Cited by 78
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme
Martini, M., Pallini, R., Luongo, G., Cenci, T., Lucantoni, C., & Larocca, L. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23805 · Cited by 77
Shum, A. M. Y., Mahendradatta, T., Taylor, R., Painter, A., Moore, M. M., Tsoli, M., Tan, T. C., Clarke, S. J., Robertson, G. R., & Polly, P. (2012) · Aging · doi:10.18632/aging.100436 · Cited by 77
Insulin action in the brain: Roles in energy and glucose homeostasis
Dodd, G. T., & Tiganis, T. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12513 · Cited by 77
Medina, E. A., Afsari, R. R., Ravid, T., Castillo, S. S., Erickson, K. L., & Goldkorn, T. (2005) · Endocrinology · doi:10.1210/en.2004-1074 · Cited by 76
Thon, M., Hosoi, T., & Ozawa, K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00138 · Cited by 75
Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats
Gan, K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i10.1572 · Cited by 78
The Role of Elongin BC-Containing Ubiquitin Ligases
Okumura, F., Matsuzaki, M., Nakatsukasa, K., & Kamura, T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00010 · Cited by 80
Kim, J. K., Kim, H., Park, S., Cederberg, A., Westergren, R., Nilsson, D., Higashimori, T., Cho, Y.-R., Liu, Z., Dong, J., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1657 · Cited by 75
MicroRNA-185 Targets SOCS3 to Inhibit Beta-Cell Dysfunction in Diabetes
Bao, L., Fu, X., Mingwen, S., Wang, Y., Ma, R., Ren, X., & Lv, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116067 · Cited by 76
IRS‐1 Regulation in Health and Disease
Schmitz‐Peiffer, C., & Whitehead, J. P. (2003) · IUBMB Life · doi:10.1080/1521654031000138569 · Cited by 78
SOCS1 in cancer: An oncogene and a tumor suppressor
Beaurivage, C., Champagne, A., Tobelaim, W. S., Pomerleau, V., Menéndez, A., & Saucier, C. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.005 · Cited by 73
Transcriptomic profiles of the bovine mammary gland during lactation and the dry period
Dai, W.-T., Zou, Y., White, R. R., Liu, J., & Liu, H. (2017) · Functional & Integrative Genomics · doi:10.1007/s10142-017-0580-x · Cited by 71
Boyle, K., Egan, P. J., Rakar, S., Willson, T. A., Wicks, I. P., Metcalf, D., Hilton, D. J., Nicola, N. A., Alexander, W. S., Roberts, A. W., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079178 · Cited by 74
Martens, N., Uzan, G., Wéry, M., Hooghe, R. J., Hooghe-Peters, E. L., & Gertler, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411596200 · Cited by 71
Regulation of cytokine receptor signaling by SOCS1
Ilangumaran, S., & Rottapel, R. K. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00020.x · Cited by 72
Zadjali, F., Santana‐Farré, R., Vesterlund, M., Carow, B., de Mirecki-Garrido, M., Hernández, I., Flodström‐Tullberg, M., Parini, P., Rottenberg, M. E., Norstedt, G., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-205583 · Cited by 74
Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling
Canettieri, G., Koo, S., Berdeaux, R., Heredia, J., Hedrick, S. A., Zhang, X., & Montminy, M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.008 · Cited by 71
Mooney, R. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208a.2006 · Cited by 75
Cullin-RING ligases in regulation of autophagy
Cui, D., Xiong, X., & Zhao, Y. (2016) · Cell Division · doi:10.1186/s13008-016-0022-5 · Cited by 73
A New Role for SOCS in Insulin Action
Krebs, D. L., & Hilton, D. J. (2003) · Science Signaling · doi:10.1126/stke.2003.169.pe6 · Cited by 78
Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects
Biobaku, F., Ghanim, H., Monte, S. V., Caruana, J. A., & Dandona, P. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa049 · Cited by 68
The interplay between obesity, immunosenescence, and insulin resistance
Shimi, G., Sohouli, M. H., Ghorbani, A., Shakery, A., & Zand, H. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00414-7 · Cited by 79
Yu, C., Mahdi, R. M., Ebong, S., Vistica, B. P., Chen, J., Guo, Y., Gery, I., & Egwuagu, C. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.737 · Cited by 69
Interaction between hepatitis C virus and metabolic factors
Kawaguchi, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i11.2888 · Cited by 69
Acute myotube protein synthesis regulation by IL-6-related cytokines
Gao, S., Durstine, J. L., Koh, H.-J., Carver, W. E., Frizzell, N., & Carson, J. A. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2017 · Cited by 69
Trobec, K. Č., von Haehling, S., Anker, S. D., & Lainščak, M. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0043-5 · Cited by 69
Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins
McCormick, S. M., & Heller, N. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00549 · Cited by 69
Cellular inflammatory responses: Novel insights for obesity and insulin resistance
Chen, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.003 · Cited by 68
Landsman, T., & Waxman, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504125200 · Cited by 68
Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism
Lin, W., Song, H., Shen, J., Wang, J., Yang, Y., Yang, Y., Cao, J., Xue, L., Zhao, F., Xiao, T., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1110926 · Cited by 74
Bower, N. I., & Johnston, I. A. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00065.2010 · Cited by 70
Diabetes: Mechanism, Pathophysiology and Management-A Review
Siddiqui, A. A., Siddiqui, S. A., Ahmad, S., Siddiqui, S., Ahsan, I., & Sahu, K. (2013) · International Journal of Drug Development and Research · Cited by 67
Favorable prognostic value of SOCS2 and IGF-I in breast cancer
Haffner, M. C., Petridou, B., Peyrat, J. P., Révillion-Carette, F., Müller‐Holzner, E., Daxenbichler, G., Marth, C., & Doppler, W. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-136 · Cited by 66
Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin
Mozafari, N., Azadi, S., Mehdi-Alamdarlou, S., Ashrafi, H., & Azadi, A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110111 · Cited by 66
The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK
Sarvas, J. L. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s13-003 · Cited by 69
Chihiro, M., Funakoshi‐Tago, M., Aoyagi, R., Ueda, F., Kimura, M., Kobata, K., Tago, K., & Tamura, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173264 · Cited by 66
do Amaral, M. E. C., Barbuio, R., Milanski, M., Romanatto, T., Barbosa, H. C. L., Nadruz, W., Bértolo, M. B., Boschero, A. C., Saad, M. J. A., Franchini, K. G., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03857.x · Cited by 66
Li, L., Grønning, L. M., Anderson, P. O., Li, S., Edvardsen, K., Johnston, J., Kioussis, D., Shepherd, P. R., & Wang, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312672200 · Cited by 64
Altered Response of Skeletal Muscle to IL-6 in Type 2 Diabetic Patients
Jiang, L. Q., Duque-Guimaraes, D. E., Machado, U. F., Zierath, J. R., & Krook, A. (2013) · Diabetes · doi:10.2337/db11-1790 · Cited by 65
The Cullin7 E3 ubiquitin ligase: A novel player in growth control
Sarikas, A., Xu, X., Field, L. J., & Pan, Z. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6922 · Cited by 67
Liu, X., Mameza, M. G., Lee, Y. S., Eseonu, C. I., Yu, C., Kang‐Mieler, J. J., & Egwuagu, C. E. (2008) · Diabetes · doi:10.2337/db07-1761 · Cited by 65
Benzene Exposure Induces Insulin Resistance in Mice
Abplanalp, W. T., Wickramasinghe, N. S. M. D., Sithu, S. D., Conklin, D. J., Xie, Z., Bhatnagar, A., Srivastava, S., & O’Toole, T. E. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy252 · Cited by 64
SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated Responses
Orr, S. J., Morgan, N. M., Buick, R. J., Boyd, C. R., Elliott, J., Burrows, J. F., Jefferies, C. A., Crocker, P. R., & Johnston, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600216200 · Cited by 64
Caruso, M. A., Ma, D., Msallaty, Z., Lewis, M. K., Seyoum, B., Al-Janabi, W., Diamond, M. P., Abou‐Samra, A., Højlund, K., Tagett, R., et al. (2014) · Diabetes · doi:10.2337/db13-1872 · Cited by 65
Spangenburg, E. E., Brown, D. A., Johnson, M. S., & Moore, R. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.104315 · Cited by 66
Chen, W., Daines, M., & Hershey, G. K. K. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.042 · Cited by 66
The UPS in diabetes and obesity
Wing, S. S. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s6 · Cited by 67
Nielsen, C., Gormsen, L. C., Jessen, N., Pedersen, S. B., Møller, N., Lund, S. A., & Jørgensen, J. O. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2414 · Cited by 63
Huang, X., Moore, D. J., Ketchum, R. J., Nunemaker, C. S., Kovatchev, B. P., McCall, A. L., & Brayman, K. L. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0006 · Cited by 62
Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression
Kanatani, Y., Usui, I., Ishizuka, K., Bukhari, A., Fujisaka, S., Urakaze, M., Haruta, T., Kishimoto, T., Naka, T., & Kobayashi, M. (2007) · Diabetes · doi:10.2337/db06-1039 · Cited by 63
Wilcox, A., Katsanakis, K. D., Bheda, F., & Pillay, T. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406101200 · Cited by 62
Kooshki, L., Zarneshan, S. N., Fakhri, S., Moradi, S. Z., & Echeverría, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154686 · Cited by 66
SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence
Mallette, F. A., Calabrese, V., Ilangumaran, S., & Ferbeyre, G. (2010) · Aging · doi:10.18632/aging.100163 · Cited by 62
Usui, I., Imamura, T., Huang, J., Satoh, H., Shenoy, S. K., Lefkowitz, R. J., Hupfeld, C. J., & Olefsky, J. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8929-8937.2004 · Cited by 61
Park, K., Li, Q., Rask‐Madsen, C., Mima, A., Mizutani, K., Winnay, J. N., Maeda, Y., D’Aquino, K. E., White, M. F., Feener, E. P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00506-13 · Cited by 60
TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis
Jiang, Y., Zhang, Q., Soderland, C., & Steinle, J. J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.003 · Cited by 61
Forrai, A., Boyle, K., Hart, A. H., Hartley, L., Rakar, S., Willson, T. A., Simpson, K., Roberts, A. W., Alexander, W. S., Voss, A. K., et al. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0323 · Cited by 65
Ramos, F. J., Langlais, P. R., Hu, D., Dong, L., & Liu, F. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00609.2005 · Cited by 60
Metadata
- Authors
- Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 44
- Pages
- 42394-42398
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2069711307
- Cited by
- 904
- References
- 44
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 18 · 2023: 25 · 2022: 35 · 2021: 39 · 2020: 27 · 2019: 29 · 2018: 42 · 2017: 33 · 2016: 48 · 2015: 27 · 2014: 50 · 2013: 51 · 2012: 57
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- SOCS1, SOCS3, IRS-1, insulin receptor substrate 2, insulin signaling, ubiquitin-mediated proteolysis, SOCS box, inflammation, insulin resistance, impaired glucose tolerance, liver, diabetes mellitus
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling 3 Protein, Elongin, Animals, Carrier Proteins, Glucose, Homeostasis, Humans, Insulin Resistance, Male, Mice, Inbred C57BL, Phosphoproteins, Proteins, Repressor Proteins, Transcription Factors, Ubiquitin, Intracellular Signaling Peptides and Proteins, Suppressor of Cytokine Signaling Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review